S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.42 (+0.90%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.42 (+0.90%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

Innovotech Stock Price, News & Analysis (CVE:IOT)

C$0.10
0.00 (0.00 %)
(As of 10/21/2019 04:00 PM ET)
Today's Range
C$0.10
Now: C$0.10
C$0.10
50-Day Range
C$0.05
MA: C$0.08
C$0.11
52-Week Range
C$0.04
Now: C$0.10
C$0.12
Volume4,500 shs
Average Volume56,427 shs
Market CapitalizationC$3.62 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Innovotech Inc. provides services and solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada and internationally. The company's products include InnovoSIL, the antimicrobial agents for coating onto or incorporation into medical devices; MBEC Assay, a screening assay used to determine the efficacy of antimicrobials against biofilms of various microorganisms; and Agress/AgreGuard, an environmentally friendly seed treatments and plant sprays to protect crops against both bacterial and fungal infections. Its products also include MBEC Assay's biofilm inoculator comprising plastic lids with 96 pegs to simulate the surface conditions on which microorganisms attach and grow. The company's services cover implant medical devices, bacteriophage and cytotoxicity testing, and in vitro antimicrobial testing, as well as antibiotic, antimicrobial, and biocide resistance. It serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food safety, transportation, and healthcare. The company is headquartered in Edmonton, Canada.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-780-4480585

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$924,786.00
Cash FlowC$0.00 per share
Book ValueC$0.00 per share

Profitability

Miscellaneous

EmployeesN/A
Market CapC$3.62 million
Next Earnings Date11/12/2019 (Estimated)
OptionableNot Optionable

Receive IOT News and Ratings via Email

Sign-up to receive the latest news and ratings for IOT and its competitors with MarketBeat's FREE daily newsletter.


Innovotech (CVE:IOT) Frequently Asked Questions

What is Innovotech's stock symbol?

Innovotech trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IOT."

When is Innovotech's next earnings date?

Innovotech is scheduled to release their next quarterly earnings announcement on Tuesday, November 12th 2019. View Earnings Estimates for Innovotech.

Has Innovotech been receiving favorable news coverage?

Press coverage about IOT stock has trended somewhat positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Innovotech earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Innovotech.

Who are some of Innovotech's key competitors?

What other stocks do shareholders of Innovotech own?

Who are Innovotech's key executives?

Innovotech's management team includes the folowing people:
  • Dr. James Timourian, Chairman, CEO, Pres & Sec.
  • Mr. Alan C. Savage, CFO & Director (Age 76)
  • Dr. Amin Omar, Chief Operating Officer
  • Dr. Merle Olson, Scientific Consultant

How do I buy shares of Innovotech?

Shares of IOT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Innovotech's stock price today?

One share of IOT stock can currently be purchased for approximately C$0.10.

How big of a company is Innovotech?

Innovotech has a market capitalization of C$3.62 million and generates C$924,786.00 in revenue each year. View Additional Information About Innovotech.

What is Innovotech's official website?

The official website for Innovotech is http://www.incomeopp-realty.com/.

How can I contact Innovotech?

Innovotech's mailing address is Suite 101, 2011-94 Street, EDMONTON, AB T6N 1H1, Canada. The company can be reached via phone at +1-780-4480585.


MarketBeat Community Rating for Innovotech (CVE IOT)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  34 (Vote Outperform)
Underperform Votes:  42 (Vote Underperform)
Total Votes:  76
MarketBeat's community ratings are surveys of what our community members think about Innovotech and other stocks. Vote "Outperform" if you believe IOT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IOT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Featured Article: Net Asset Value

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel